# Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

> **NCT01971450** · — · COMPLETED · sponsor: **Bayer** · enrollment: 89 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** Iloprost (Ventavis, BAYQ6256)

## Key facts

- **NCT ID:** NCT01971450
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-21
- **Primary completion:** 2017-06-28
- **Final completion:** 2018-04-18
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971450, "Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01971450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
